Contemporary Use of β-Blockers in Heart Failure Patients With and Without Atrial Fibrillation: A ...

Contemporary Use of β-Blockers in Heart Failure Patients With and Without Atrial Fibrillation: A ...

02:50 |

Related Videos

The new European Society of Cardiology acute coronary syndrome guideline and its impact in the CP...

The new European Society of Cardiology acute coronary syndrome guideline and its impact in the CP...

The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients...

The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients...

Oral Anticoagulant treatment and the risk of dementia in patients with atrial fibrillation.

Oral Anticoagulant treatment and the risk of dementia in patients with atrial fibrillation.

2024 ESC Guidelines for Management of Elevated BP and Hypertension: Key Points

2024 ESC Guidelines for Management of Elevated BP and Hypertension: Key Points

Ticagrelor monotherapy the way forward after Percutaneous Coronary Interventions: An updated meta...

Ticagrelor monotherapy the way forward after Percutaneous Coronary Interventions: An updated meta...

Living Well With Schizophrenia | Dr. S. Gopinath

Living Well With Schizophrenia | Dr. S. Gopinath

Demo

Demo

demo

demo

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Sajal Kamat

HbA1c = High Baseline A1c in a middle-aged patient with short duration diabetes | Dr. Sajal Kamat

2023 ESH Guideline for the Management of Hypertension with specific focus on Beta blockers

2023 ESH Guideline for the Management of Hypertension with specific focus on Beta blockers

Demo

Demo

Real World Experience with Empa-Lina FDC(an Indian Perspective) case 1 | Dr. Supratik Bhattacharyya

Real World Experience with Empa-Lina FDC(an Indian Perspective) case 1 | Dr. Supratik Bhattacharyya

ACC Expert Consensus statement 2024 for Treatment of HFrEF: Key Points

ACC Expert Consensus statement 2024 for Treatment of HFrEF: Key Points

Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial

Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial

THE ADAPTABLE STUDY

THE ADAPTABLE STUDY

Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE trial

Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE trial

Latest Update in Hypertension | Dr. Nabeel Haneefa

Latest Update in Hypertension | Dr. Nabeel Haneefa

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real ...

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real ...

Living Well With Schizophrenia | Dr. Angad Singh Kochar

Living Well With Schizophrenia | Dr. Angad Singh Kochar

© 2024 Tubidy